Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Assets, Current [Abstract]
Cash and cash equivalents	$ 38,142	$ 38,241
Restricted cash	164,937	256,237
Derivatives	18,873	17,958
Prepaid expenses and other current assets	2,103	2,089
Total current assets	224,055	314,525
Property, plant and equipment, net	3,733,783	2,437,733
Operating lease right-of-use assets	168,255	170,827
Debt issuance costs	357,903	389,695
Derivatives	257,622	0
Other non-current assets	15,556	11,021
Total assets	4,757,174	3,323,801
Current liabilities:
Accounts payable	131,800	243,129
Accrued and other current liabilities	364,909	306,115
Operating leases	2,846	3,143
Total current liabilities	499,555	552,387
Debt, net	2,833,809	1,816,301
Operating leases	145,026	145,962
Derivatives	0	66,899
Other non-current liabilities	0	1,818
Total liabilities	3,478,390	2,583,367
Commitments and contingencies (Note 11)
Stockholders’ equity
Common stock, $0.0001 par value, 480.0 million authorized: 257.9 million and 256.5 million outstanding, respectively	26	26
Treasury stock: 2.2 million shares and 2.2 million respectively, at cost	(14,367)	(14,214)
Preferred stock, $0.0001 par value, 0.5 million authorized: none outstanding	0	0
Additional paid-in-capital	1,043,307	693,883
Accumulated deficit	(396,002)	(391,772)
Total stockholders’ equity	632,964	287,923
Non-controlling interest	645,820	452,511
Total equity	1,278,784	740,434
Total liabilities and equity	$ 4,757,174	$ 3,323,801